Reactive oxygen species modulates the intracellular level of HBx viral oncoprotein

Biochemical and Biophysical Research Communications

Volumn 310, Issue 1, 2003, Pages 32-39

  Wang, Jin Hee ^a   Yun, Chawon ^a   Kim, Sujeong ^a   Lee, Jae Ho ^a   Yoon, Gyesoon ^a   Lee, Mi Ock ^b   Cho, Hyeseong ^a  

^a Ajou University School of Medicine   (South Korea)

^b Sejong University   (South Korea)

Author keywords

Adriamycin; Antioxidants; Gene expression; HBV; HBx; ROS

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; HEPATITIS B VIRUS X PROTEIN; HYDROGEN PEROXIDE; ONCOPROTEIN; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; MODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

HEPATITIS B VIRUS;

EID: 0141849146     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.113     Document Type: Article

References (44)

1. Buendia M.A. Hepatitis B viruses and hepatocellular carcinoma. Adv. Cancer Res. 59:1992;167-226.
2. Schödel F.R., Sprengel T., Weiner D., Fernbolz R., Schneider R.J., Will H. Animal hepatitis B viruses. Klein G. Advances in Viral Oncology. 1989;73-102 Raven Press, New York.
3. Diago J., Garces R., Richardson C.D. X protein of hepatitis B virus modulates cytokine and growth factor related transduction pathways during the course of viral infection and hepatocarcinogenesis. Cytokines Growth Factor Rev. 12:2001;189-205.
4. Diao J., Khine A.A., Sarangi F., Hsu E., Iorio C., Tibbles L.A., Woodgett J.R., Penninger J., Richardson C.D. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J. Biol. Chem. 276:2001;8328-8340.
5. Doria M., Klein N., Lucito R., Schneider R.J. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J. 14:1995;4747-4757.
6. Klein N.P., Schneider R.J. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol. Cell. Biol. 17:1997;6427-6436.
7. Shih W.L., Kuo M.L., Chuang S.E., Cheng A.L., Doong S.L. Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 275:2000;25858-25864.
8. Lin Y., Tang H., Nomura T., Dorjsuren D., Hayashi N., Wei W., Ohta T., Roeder R., Murakami S. The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators. J. Biol. Chem. 273:1998;27097-27103.
9. Lin Y., Nomura T., Cheong J., Dorjsuren D., Iida K., Murakami S. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J. Biol. Chem. 272:1997;7132-7139.
10. Kim Y.C., Song K.S., Yoon G., Nam M.J., Ryu W.S. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. Oncogene. 20:2001;16-23.
11. Shirakata Y., Kawada M., Fujiki Y., Sano H., Oda M., Yaginuma K., Kobayashi M., Koike K. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn. J. Cancer Res. 80:1989;617-621.
12. Koike K., Moriya K., Iino S., Yotsuyanagi H., Endo Y., Miyamura T., Kurokawa K. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 19:1994;810-819.
13. Yu D.Y., Moon H.B., Son J.K., Jeong S., Yu S.L., Yoon H., Han Y.M., Lee C.S., Park J.S., Lee C.H., Hyun B.H., Murakami S., Lee K.K. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J. Hepatol. 31:1999;123-132.
14. Jin Y.M., Yun C., Park C., Wang H.J., Cho H. Expression of hepatitis B virus X (HBx) protein is closely correlated with the high periportal inflammatory activity of liver diseases. J. Viral Hepatitis. 8:2001;330-332.
15. Su Q., Schroder C.H., Hofmann W.J., Otto G., Pichimayr R., Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinoma. Hepatology. 27:1998;1109-1120.
16. Antonucci T.K., Rutter W.J. Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner. J. Virol. 63:1989;579-583.
17. Ohno H., Kaneko S., Kobayashi K., Murakami S. Human hepatitis B virus enhancer 1 is responsive to human interleukin-6. J. Med. Virol. 52:1997;413-418.
18. Raney A.K., Milich D.R., Easton A.J., McLachlan A. Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J. Virol. 64:1990;2360-2368.
19. Dandri M., Petersen J., Stockert R.J., Harris T.M., Rogler C.E. Metabolic labeling of woodchuck hepatitis B virus X protein in naturally infected hepatocytes reveals a bimodal half-life and association with the nuclear framework. J. Virol. 72:1998;9359-9364.
20. Schek N., Bartenschlager R., Kuhn C., Schaller H. Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene. 6:1991;1735-1744.
21. Bergametti F., Sitterlin D., Transy C. Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. J. Virol. 76:2002;6495-6501.
22. Lee S.W., Lee Y.M., Bae S.K., Murakami S., Yun Y., Kim K.W. Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem. Biophys. Res. Commun. 268:2000;456-461.
23. Yun C., Lee J.H., Park H., Jin Y.M., Park S., Park K., Cho H. Chemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein expressing liver cells. Oncogene. 19:2000;5163-5172.
24. Yun C., Lee J.H., Wang J.H., Seong J.K., Oh S.H., Yu D.Y., Cho H. Expression of hepatitis B virus X (HBx) gene is up-regulated by adriamycin at the post-transcriptional level. Biochem. Biophys. Res. Commun. 296:2002;1157-1163.
25. Selles M.A., Chen M.L., Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA. 84:1987;1005-1009.
26. Alexander J.J., Bey E.M., Geddes E.W., Lecatsas G. Establishment of a continuously growing cell line from primary carcinoma of the liver. S. Afr. Med. J. 5:1976;2124-2128.
27. Shamay M., Agami R., Shaul Y. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer. Oncogene. 20:2001;6811-6819.
28. Kang Y.H., Park S.H., Lee Y.J., Kang J.S., Kang I.J., Shin H.K., Park J.H., Bunger R. Antioxidant alpha-keto-carboxylate pyruvate protects low-density lipoprotein and atherogenic macrophages. Free Radic. Res. 36:2002;905-914.
29. Ono Y., Yoshimasu T., Ashikaga R., Inoue M., Shindou H., Fuji K., Araki Y., Nishimura Y. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am. J. Clin. Oncol. 23:2000;564-568.
30. Zhou S., Palmeira C.M., Wallace K.B. Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol. Lett. 121:2001;151-157.
31. Imazeki F., Yaginuma K., Omata M., Okuda K., Kobayashi M., Koike K. RNA transcripts of hepatitis B virus in hepatocellular carcinoma. Hepatology. 7:1987;753-757.
32. Hu Z., Zhang Z., Doo E., Coux O., Goldberg A.L., Liang T.J. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol. 73:1999;7231-7240.
33. Fischer M., Runkel L., Schaller H. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genes. 10:1995;99-102.
34. Sirma H., Weil R., Rosmorduc O., Urban S., Israel A., Kremsdorf D., Brechot C. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogene. 16:1998;2051-2063.
35. Zhang Z., Torii N., Furusaka A., Malayaman N., Hu Z., Liang T.J. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J. Biol. Chem. 275:2000;15157-15165.
36. Rahmani Z., Huh K.W., Lasher R., Siddiqui A. Hepatitis B virus Xprotein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J. Virol. 74:2000;2840-2846.
37. Akada S., Shirakata Y., Kaneniwa N., Koike K. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene. 18:1999;6965-6973.
38. Waris G., Huh K.W., Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-κ B via oxidative stress. J. Virol. 21:2001;7721-7730.
39. Hensley K., Robinson A., Gabbita S.P., Salsman S., Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 28:2000;1456-1462.
40. Laroux F.S., Pavlick K.P., Hines I.N., Kawachi S., Harada H., Bharwani S., Hoffman J.M., Grisham M.B. Role of nitric oxide in inflammation. Acta Physiol. Scand. 173:2001;113-118.
41. Lara-Pezzi E., Majano P.L., Gomez-Gonzalo M., Garcia-Monzon C., Moreno-Otero R., Levrero M., Lopez-Cabrera M. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology. 28:1998;1013-1021.
42. Lee Y., Park U.S., Choi I., Yoon S.K., Park Y.M., Lee Y.I. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clin. Cancer Res. 4:1998;1711-1717.
43. Heinz D., Peters M., Prange R., Gerken G., Rose-John S. Possible role of human interleukin-6 and soluble interleukin-6 receptor in hepatitis B virus infection. J. Viral Hepat. 8:2001;186-193.
44. Waris G., Siddiqui A. Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J. Virol. 76:2002;2721-2729.